ResMed Inc. (RMD)
ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co.'s operating segments are: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.
RMD SEC Filing Email Alerts Service
Company Name: |
ResMed Inc. |
Website: |
www.resmed.com |
Sector: |
Medical Instruments & Supplies |
Number of ETFs Holding RMD: |
91 |
Total Market Value Held by ETFs: |
$4.97B |
Total Market Capitalization: |
$28.56B |
% of Market Cap. Held by ETFs: |
17.40% |
|
|
March 29, 2024 7:59 AM Eastern
Buy (3.32 out of 4)
45th percentile
|
|